Home/Filings/4/0001604643-23-000099
4//SEC Filing

Lamb Martin 4

Accession 0001604643-23-000099

CIK 0001604643other

Filed

May 25, 8:00 PM ET

Accepted

May 26, 4:45 PM ET

Size

11.6 KB

Accession

0001604643-23-000099

Insider Transaction Report

Form 4
Period: 2023-05-24
Lamb Martin
Director
Transactions
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2023-05-2444,9030 total
    Exercise: $4.64Exp: 2024-05-12Common Stock (44,903 underlying)
  • Disposition to Issuer

    Common Stock

    2023-05-2449,7110 total(indirect: By Trust)
  • Disposition to Issuer

    Common Stock

    2023-05-2416,2390 total
  • Disposition to Issuer

    Common Stock

    2023-05-2440,0000 total(indirect: By FIC)
Footnotes (6)
  • [F1]Disposed of pursuant to the merger agreement among Xylem Inc., Fore Merger Sub, Inc. and the issuer, dated as of Jan. 22, 2023. Upon effectiveness of the merger on May 24, 2023, (i) each issued and outstanding share of issuer common stock was exchanged for 0.48 Xylem common shares, with cash paid in lieu of fractional shares, and (ii) unvested restricted stock units ("RSUs") were converted into RSUs for Xylem common shares, by multiplying the number of shares of issuer common stock underlying the award and 0.48, rounded down to the nearest whole share.
  • [F2]Disposed of upon effectiveness of the merger, in which each issued and outstanding share of issuer common stock was exchanged for 0.48 Xylem common shares, with cash paid in lieu of fractional shares.
  • [F3]Shares held by a Bare trust, for the benefit of the reporting person's immediate family members and for which the reporting person retains investment control.
  • [F4]Shares held by an FIC, for which the reporting person retains investment control. The reporting person disclaims beneficial ownership with respect to these securities except to the extent of his pecuniary interest therein.
  • [F5]This option is fully vested. Pursuant to the merger agreement, each unexercised option to purchase issuer common stock was assumed by Xylem and converted into an option to purchase Xylem common shares. The number of Xylem common shares subject to the Xylem option is equal to the number of shares of issuer common stock underlying the options multiplied by 0.48, rounded down to the nearest whole share.
  • [F6]Pursuant to the merger agreement, the Xylem option exercise price is equal to the issuer option exercise price divided by 0.48, rounded up to the nearest whole cent.

Issuer

Evoqua Water Technologies Corp.

CIK 0001604643

Entity typeother

Related Parties

1
  • filerCIK 0001720857

Filing Metadata

Form type
4
Filed
May 25, 8:00 PM ET
Accepted
May 26, 4:45 PM ET
Size
11.6 KB